Bacterial vaginosis, which is caused by bacteria overgrowing in the vagina, can be hard to treat, with women often experiencing recurring symptoms. Now it seems that asking their male sexual partners...

Aussie sex scientists say that when it comes to recurring bacterial vaginosis, men can help by getting to work on their own down under.

Recent scientific advancements have transformed our understanding of sexual health, bringing to light the important classification of bacterial vaginosis (BV) as a sexually transmitted infection (STI). This revelation affects nearly one in three women worldwide and demands a reconsideration of conventional treatment methods. Bacterial Vaginosis: A Common Yet Misunderstood Infection Bacterial vaginosis is a prevalent condition that has long been misconstrued.

A common vaginal infection that affects nearly 1 in 3 women worldwide should be reclassified as a sexually transmitted infection (STI), a new study suggests. Ba

Study shows that male partners can help in limiting recurrence of the condition afflicting almost one in three womenGet our breaking news email, free app or daily news podcast Like almost one in three...

The ecosystem in the vagina helps to keep it healthy. Scientists looking for ways to support these microbes have revealed unexpected and intriguing interactions.

YouTube video by MelanieHamlett

Aussie sex scientists say that when it comes to recurring bacterial vaginosis, men can help by getting to work on their own down under.

If you've gotten a diagnosis of bacterial vaginosis, you might be wondering, "Is BV an STI?" We're answering this question and more.

In a clinical trial, treating both partners in a relationship significantly reduced the likelihood of recurrence of bacterial vaginosis.

Recent findings from a groundbreaking randomized controlled trial in Australia have highlighted an innovative approach to tackling bacterial vaginosis (BV) by including antibiotic treatment for male partners. Published in the New England Journal of Medicine, this study suggests that such treatment significantly lowers the recurrence of BV in women. Key Insights from the Trial The trial, which was halted early due to promising results, demonstrated that women who received first-line antibiotics alongside their male partners—who also underwent topical and oral antibiotic treatment—experienced a 50% reduction in BV recurrence compared to women who were treated alone.